The Middle East veterinary vaccines market was valued at USD 678.3 million in 2025, is projected to reach USD 1,053.3 million by 2035 and is forecast to register a 4.0% CAGR between 2025 and 2035. In 2025, live attenuated vaccines hold 45% of vaccine type demand and veterinary hospitals represent 42% of end user sales.